MEDIFLORA PHARMACY
Adalimumab

Adalimumab

Send Inquiry

Adalimumab, Humira Adalimumab is the third TNF inhibitor, after infliximab and etanercept, to be approved in the United States .

Humira (adalimumab) reduces the effects of a substance in the body that can cause inflammation. Humira is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and and a chronic skin condition called hidradenitis suppurativa.